BioCentury
ARTICLE | Clinical News

TGF-Beta 3: Began Phase IA trial in healthy volunteers to obtain baseline data on cell division in the oral cavity

January 3, 1995 8:00 AM UTC

Oncogene Science Inc. (ONCS), Uniondale, N.Y. Product: TGF-Beta 3 Indication: Prevent oral mucositis in chemotherapy Status: Began Phase IA trial in healthy volunteers to obtain baseline data on cell ...